J&J JIVES and 3 Hot Stocks Actively Busy on Trader Radars

General Electric Co. (NYSE:GE): GE Healthcare and BGI, the world’s largest genomics organization, has entered a research collaboration in stem cell science. The collaboration is an attempt to advance the possible global utility of assays derived from stem cells to be used in drug discovery and toxicity testing by examining and understanding the underlying genetic differences between the stem cell lines of ethnically diverse humans. GE shares recently traded at $19.44, down $0.04, or 0.21%.

Johnson & Johnson (NYSE:JNJ): Shares jumped 2% to $64.70 following three firms upgrade shares, then faded into the afternoon. One of J&J’s subsidiaries, Janssen Pharma, revealed it would up its J&J stake in the framework of an acquisition. The 3 wall street firms (JPMorgan, Jefferies, and Raymond James) have responded with positive notes today. JNJ shares recently traded at $63.60, up $.52, or .83%.

Investing Insights: Why is Johnson & Johnson Buying $12.9 Billion of This Stock?

Citigroup, Inc. (NYSE:C): Bloomberg reports that according to Michael Bennet, head of the bank’s derivatives and structured finance, the World Bank could possibly issue yuan-dominated bonds in Hong Kong again once borrowing costs decrease. C shares recently traded at $27.71, up $0.09, or 0.33%.

Chesapeake Energy Corporation (NYSE:CHK): Reuters reports, the board is close to reaching a decision regarding who will claim the independent chairman position. CHK shares recently traded at $17.06, down $0.41, or 2.38%.

Don’t Miss: Jamie Dimon: JPMorgan’s Trading Strategy FAILED Because It Was Untested.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.